A new study examined how treatments for atrial fibrillation (Afib) affected cognitive decline and frailty. Treating heart rate compared to rhythm was linked to a greater rate of cognitive decline, the ...
A sub-study analysis of the EAST—AFNET 4 trial revealed how genetic risk for atrial fibrillation (AF) and stroke interacts with early rhythm control therapy: Early rhythm control reduces ...
BOSTON, June 24, 2020 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a late-stage biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare ...
The study enrolled approximately 12,000 patients in the U.S. who were at least 70 years old with no history of atrial fibrillation. Roughly half the patients were randomly assigned to receive a ...
Years of high-intensity exercise may come with an unexpected heart risk for male endurance athletes over the age of 50, according to new research from the University of Leeds. The study, published ...
Rhythm Pharmaceuticals RYTM announced that it is modifying the design of its two ongoing clinical studies that are evaluating its lead pipeline candidate setmelanotide as a precision medicine for ...
Some people might seem like they were born with rhythm – and a new study suggests there's some truth to it. Scientists have found that newborns can predict musical patterns from just two days old and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results